GSK was able to avert industrial action at ... The Unite union, representing around 160 workers at the Montrose site, said the offer constitutes a “substantial real terms pay cut” given ...
"The £50m represents a vote of confidence in the Montrose site and team by GSK and further underpins the site's renaissance. "We expect to increase our headcount by up to 20% over the coming ...
It is believed about 200 roles will be cut at the facility in Barnard Castle, County Durham, in October 2025. The team ...
The site at Ulverston currently belongs to GlaxoSmithKline (GSK), which is winding down its operation there ahead of closure in 2025. Staff manufacture antibiotics under the brand name Zinnat.
GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and ...
Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...
It has now confirmed Sandoz has decided not to renew its contract. The move comes as GSK confirmed it was shutting its site at Ulverston, Cumbria, which has also been producing the antibiotic for ...
GSK PLC GSK shares slipped 1.84% to £15.75 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.91% to 8,328.72. Supported ...